文献速递关节外科

术中滑液钙卫蛋白即时侧流试验诊断髋膝关节置换翻修术后假体周围感染的前瞻性评估

Prospective Evaluation of an Intraoperative Synovial Calprotectin Point-of-Care Lateral Flow Test for Periprosthetic Joint Infection in Hip and Knee Revisions.
PubMed 文献 · J Arthroplasty · 2026-10-27

这项前瞻性研究纳入80例髋或膝关节翻修术患者,术中新鲜滑液用专用钙卫蛋白侧流试验检测,以2018 ICM标准为参考。以50 mg/L为阈值,髋翻修灵敏度91.7%、特异度90.3%、AUC 0.894;膝翻修灵敏度87.5%、特异度100%、AUC 0.930。结论认为该即时检测诊断性能高,可作为综合诊断框架内的辅助工具。

要点

  • 术中滑液钙卫蛋白侧流试验以50 mg/L为阈值,在髋膝翻修中均显示高诊断性能。
  • 髋翻修AUC 0.894,膝翻修AUC 0.930,膝翻修特异度达100%。
  • 假阳性见于金属沉着病、近期脱位及不明原因炎症;假阴性见于真菌感染和培养阴性伴窦道PJI。

核心结论

  • 术中滑液钙卫蛋白即时侧流试验以50 mg/L为阈值,在髋和膝关节翻修术中诊断假体周围感染具有高诊断性能。
  • 该检测周转快且阴性预测值高,可作为综合诊断框架内实时手术决策的可靠辅助工具。

研究设计与样本

  • 前瞻性连续纳入2022年3月至2026年2月期间接受髋或膝关节翻修术的80例患者。
  • 55例髋翻修中24例为PJI、31例为无菌性失败;25例膝翻修中8例为PJI、17例为无菌性失败。
  • 以2018国际共识会议(ICM)标准为参考标准,术中抽取新鲜滑液用专用钙卫蛋白侧流试验检测。

主要发现

  • 髋翻修中,感染患者滑液钙卫蛋白中位数138 mg/L,无菌性失败患者为7 mg/L。
  • 膝翻修中,感染患者滑液钙卫蛋白中位数106.5 mg/L,无菌性失败患者为7 mg/L。
  • 髋翻修灵敏度91.7%(95%CI 73.0-99.0),特异度90.3%(95%CI 74.2-98.0),AUC 0.894(95%CI 0.81-0.98)。
  • 膝翻修灵敏度87.5%(95%CI 47.3-99.7),特异度100%(95%CI 80.5-100),AUC 0.930(95%CI 0.84-1.00)。
  • 3例假阳性分别与金属沉着病、近期脱位和不明原因炎症相关;3例假阴性分别与真菌病原体和培养阴性伴窦道PJI相关。

关键数值与推荐

  • 诊断阈值采用滑液钙卫蛋白≥50 mg/L。
  • 参考标准为2018 ICM标准。
  • 髋翻修灵敏度91.7%(95%CI 73.0-99.0)、特异度90.3%(95%CI 74.2-98.0)、AUC 0.894(95%CI 0.81-0.98)。
  • 膝翻修灵敏度87.5%(95%CI 47.3-99.7)、特异度100%(95%CI 80.5-100)、AUC 0.930(95%CI 0.84-1.00)。

临床怎么用

  • 在髋或膝关节翻修术中,可抽取新鲜滑液行钙卫蛋白侧流试验,以50 mg/L为阈值辅助实时排除或支持PJI。
  • 该检测周转快、阴性预测值高,适合在综合诊断框架内作为术中决策的辅助工具。
  • 结果解读需结合临床,注意金属沉着病、近期脱位、不明原因炎症及真菌感染、培养阴性伴窦道等可能造成假阳性或假阴性。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Synovial calprotectin measured by lateral flow assay (LFT) has emerged as a promising point-of-care (POC) biomarker for periprosthetic joint infection (PJI). However, existing studies are limited by retrospective designs, frozen sample use, off-label stool test application, and small sample sizes. This prospective study evaluated the diagnostic accuracy of an intraoperative synovial calprotectin POC-LFT in hip and knee revision arthroplasty. METHODS: A consecutive cohort of 80 patients undergoing revision total hip or knee arthroplasty (THA, TKA) was prospectively enrolled between March 2022 and February 2026. The 2018 International Consensus Meeting (ICM) criteria served as the reference standard. Among 55 THA revisions, 24 patients had PJI and 31 had aseptic failure. Among 25 TKA revisions, eight had PJI and 17 aseptic failure. Synovial fluid was aspirated intraoperatively and tested fresh using a dedicated calprotectin LFT. Using a threshold of ≥ 50 mg/L, sensitivity, specificity, predictive values, and area under the receiver operating characteristic curve (AUC) were calculated. RESULTS: Median calprotectin was 138 mg/L in infected versus seven mg/L in aseptic THA patients. Sensitivity was 91.7% (95% confidence interval (CI), 73.0 to 99.0), specificity 90.3% (95% CI, 74.2 to 98.0), and AUC 0.894 (95% CI, 0.81 to 0.98). Median calprotectin was 106.5 mg/L in infected versus seven mg/L in aseptic TKA patients. Sensitivity was 87.5% (95% CI, 47.3 to 99.7), specificity 100% (95% CI, 80.5 to 100), and AUC 0.930 (95% CI, 0.84 to 1.00). There were three false-positive cases (metallosis, recent dislocation, and unexplained inflammation), while three false-negatives were associated with fungal pathogen and culture-negative PJI with sinus tract. CONCLUSION: The intraoperative synovial calprotectin POC-LFT demonstrated high diagnostic performance in both THA and TKA revisions using a threshold of 50 mg/L. Its rapid turnaround time and high negative predictive value make it a reliable adjunct for real-time surgical decision-making within a comprehensive diagnostic framework.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Giatroudakis K, Iliopoulos E, Kateros K, et al. Prospective Evaluation of an Intraoperative Synovial Calprotectin Point-of-Care Lateral Flow Test for Periprosthetic Joint Infection in Hip and Knee Revisions. J Arthroplasty. 2026. PMID: 42946101. doi:10.1016/j.arth.2026.10.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。